<DOC>
	<DOCNO>NCT01023165</DOCNO>
	<brief_summary>The purpose study determine restore normal metabolic function patient type 1 type 2 diabetes improve impact consequence diabetic complication overall health quality life diabetic patients.Patients treat per week intensive bolus intravenous insulin delivery mimic normal insulin secretion non diabetic individual . Baseline periodic diagnostic test perform questionnaire complete evaluate monitor progress outcome .</brief_summary>
	<brief_title>Effects Intensive Bolus Intravenous Insulin Delivery Metabolic Integrity Type 1 Type 2 Diabetes</brief_title>
	<detailed_description>It know glucose metabolic pathway primary fuel generator brain , nerve tissue , heart , vascular tissue , eye , kidney liver . Deficient metabolism state see glucose metabolism experience many diabetic patient lead complication . These damaging effect exacerbate alter cellular metabolite , specifically increase catabolic decrease anabolic factor . It show past 20 year normalization metabolism diabetic patient accomplish mimic normal endogenous insulin pattern pancreas . Intensive intravenous insulin bolus demonstrate reverse metabolic state primary fat utilization carbohydrate utilization monitoring subject 's respiratory quotient . This study measure whether reversal abnormal metabolism patient diabetes correlated improvement quality life associate complication relate diabetes . The respiratory quotient ( RQ ) measurement CO2 exhale O2 inhale proportionate fuel source use body , primarily liver short period time . The high RQ , glucose less alternative fuel source utilize . Following RQ change help determine effectiveness physiological intravenous bolus insulin administration increase anabolic function diabetic individual . By improve body 's glucose metabolism thereby cause beneficial effect anabolic factor , possibility serious complication may decrease . In addition , use oral carbohydrate time along physiologic intravenous bolus insulin administration stimulates appropriate gut hormone augment effect , response duplicate intravenous glucose . The purpose study determine whether physiologic administration intravenous bolus insulin along augment effect oral carbohydrate normalize metabolism diabetic patient improve metabolic integrity quality life index . The RQ determine use metabolic cart . Individuals breathe mask 3-5 minute rest period 20 minute . The ratio exhale volume CO2 inhale volume O2 determine RQ . The physiologic range 0.7 to1.3 . Individuals use fat primary fuel ratio 0.7 , protein mixed fuel 0.8-0.9 carbohydrate 0.9-1.0 . Those take excessive calorie RQ 's high 1.05 . The RQ follow serially monitor progress aand outcomes do sixty minute intravenous bolus insulin treatment session , 3 successive session single treatment day . The amount intravenous insulin oral glucose give determine monitor RQ change previous session.Intravenous bolus insulin therapy encourage glucose metabolism diabetic normalize metabolic integrity multiple organ , especially muscle , retina , liver , kidney nerve ending . The process fundamentally require administration high dose intravenous insulin bolus similar find non diabetic human pancreas surround portal circulation . Oral carbohydrate give simultaneously augment process prevent hypoglycemia . The process monitor frequent glucose level respiratory quotient ( RQ ) . RQ measure metabolic cart determines ratio VCO2/ VO2 . This ratio specific fuel use one time body . The glucose level monitor every thirty minute frequently medically necessary keep glucose level appropriate RQ determines need readjust infusion protocol patient subsequent intravenous bolus insulin infusion sessions.Patient evaluate post session discharge stable . Frequent monitoring RQ glucose necessary level change rapidly , depend fuel utilize body . Intravenous bolus insulin therapy shift metabolism primarily fatty acid metabolism primarily glucose metabolism . This shift reflect increase respiratory quotient . However rest period RQ may fall back low level . Therefore RQ 's do begin end insulin infusion session 1 hour order appropriately monitor adjust insulin carbohydrate load reach optimal activation session .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Diagnosed significant complication result diabetes Ability swallow without difficulty Ability perform Respiratory Quotient requirement breathe mask 3 minute time Supervising physician must evaluate diagnose one follow medical condition eligible participate study Hypoglycemia unawareness Significant proteinuria ( &gt; 300 mg/24 hr ) spite ACE inhibitor and/or ARB 's . Diabetic nephropathy Progressive , significant diabetic peripheral neuropathy . Orthostatic hypotension due autonomic neuropathy advance diabetes . Advanced gut neuropathy gastroparesis diabetic diarrhea . Nonhealing diabetic wound Diabetic retinopathy Lack intravenous access Inability breathe respiratory quotient machine Subjects dialysis Presence severe underlie chronic disease ( e.g . coronary artery disease , hepatic disease ) opinion investigator likely preclude subject complete full term study Inability stabilize blood pressure 140/90 use ACE inhibitor , Ca channel blocker , Alpha 1 blocker , central Alpha2 agonist diuretic Pregnancy contemplate pregnancy Alcohol abuse , drug addiction use illegal drug Active liver disease Active chemotherapy Positive HIV Subjects history poor compliance drug diet placebo therapy keep appointment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Metabolic Integrity</keyword>
	<keyword>Intravenous Bolus Insulin</keyword>
</DOC>